For comments, suggestions
Created with Raphaël 2.1.0 31.08.2017 Filing date 01.03.2019 Validation fee payment 31.08.2019 (A1) Patent application published 31.01.2025 Can request protection in MD until

Patent not validated (the request for validation was not submitted on time)


(210)Number of the EPO application17771619
(220)Filing date of the EPO application2017.08.31
(80)EPO patent specification publication (B)EPB nr. 31/2024, 2024.07.31
(110)EPO patent number3506931
(21)Number of the applicatione 2019 0757
(71)Name(s) of applicant(s), code of the countryRegeneron Pharmaceuticals, Inc., US;
Sanofi Biotechnology, FR;
(72)Name(s) of inventor(s), code of the countryHAMILTON Jennifer D., US;
SWANSON Brian N., FR;
(73)Name(s) of owner(s), code of the countryREGENERON PHARMACEUTICALS, INC., US;
Sanofi Biotechnology, FR;
(54)Title of the inventionMETHODS FOR PREVENTING OR TREATING ALLERGY BY ADMINISTERING AN IL-4R ANTAGONIST
(13)Kind-of-document code A1
(51)International Patent Classification A61K 39/00 (2006.01.01); C07K 16/28 (2006.01.01); A61P 37/08 (2006.01.01)
(19)CountryUS
(41)Date of publication of the application2019.08.31
(30)Priority201662382501 P, 2016.09.01, US; 201662425726 P, 2016.11.23, US
(86)International applicationPCT/US2017/049538, 2017.08.31
(87)International publicationWO 2018/045130, 2018.03.08
Up
/Inventions/details/3506931